Bill Gates Gives $50 Million to Combat Alzheimer's - NBC10 Boston
National & International News
The day’s top national and international news

Bill Gates Gives $50 Million to Combat Alzheimer's

In a statement, Gates says men in his family have suffered from Alzheimer's

Find NBC Boston in your area

Channel 10 on most providers

Channel 15, 60 and 8 Over the Air

    processing...

    NEWSLETTERS

    Bill Gates Gives $50 Million to Combat Alzheimer's
    Yana Paskova/Getty Images, File
    In this file photo, Bill Gates listens to former President Barack Obama answer questions at the Gates Foundation Inaugural Goalkeepers event on Sept. 20, 2017, in New York City. Gates says he's giving $50 million to help fight Alzheimer's disease. The Microsoft co-founder said Monday, Nov. 13, 2017, that the donation to the Dementia Discovery Fund is personal and not through his charitable foundation.

    Bill Gates says he's giving $50 million to help fight Alzheimer's disease.

    The Microsoft co-founder said Monday that the donation to the Dementia Discovery Fund is personal and not through his charitable foundation.

    The London-based private fund is backed by government, charities and pharmaceutical firms and seeks new treatments for the progressive, irreversible neurological disease.

    In a statement, Gates says men in his family have suffered from Alzheimer's. He says he's hopeful that in time Alzheimer's could be a chronic condition treatable with medication.

    Survivor of Santa Fe HS Shooting: 'I Was Scared for My Life'

    [NATL] Survivor of Santa Fe High School Shooting: 'I Was Scared for My Life'

    Dakota Shrader, a student from Santa Fe High School, describes what happened when shots were fired during her morning history class. Multiple people died during the shooting.

    (Published Friday, May 18, 2018)

    Gates says the first treatments for the disease might not be feasible for a decade or more and would initially be expensive. He says the Gates Foundation might consider how to expand access in poorer countries when treatments are developed.